David R. Sibley

190

Publications

19.9K

Citations

H-Index

1979

Active since

Affiliations

National Institute of Neurological Disorders and Stroke(Current)

National Institutes of Health

National Institute of Mental Health

Rosalind Franklin University of Medicine and Science

National Institute on Drug Abuse

David R. Sibley is an author at National Institute of Neurological Disorders and Stroke specializing in medicine, pharmacology, and neuropharmacology.

ORCID

Top concepts

MedicinePharmacologyNeuropharmacologyNeuroscienceDopamine ResearchMolecular PharmacologyPhysiologySignal TransductionSocial SciencesBiochemistry

Publications per year

1979–2024

190

Publications

190

D <sub>1</sub> and D <sub>2</sub> Dopamine Receptor-regulated Gene Expression of Striatonigral and Striatopallidal Neurons

Charles R. Gerfen, Thomas M. Engber, Lawrence C. Mahan et al. · Science · 1990 · 2.9K citations

Aripiprazole, A Novel Atypical Antipsychotic Drug with a Unique and Robust Pharmacology

Sean M Renock, Elaine G. Arrington, Louis A. Chiodo et al. · Neuropsychopharmacology · 2003 · 962 citations · Full text

Psychoactive Drug, Pharmacological Study, Psychiatry +9

Multiple D2 dopamine receptors produced by alternative RNA splicing

Frederick J. Monsma, Loris D. McVittie, Charles R. Gerfen et al. · Nature · 1989 · 645 citations

Alternative Rna Splicing, Neuropharmacology, Neuroscience +4

Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs.

Frederick J. Monsma, Yong Shen, Raymond P. Ward et al. · Molecular Pharmacology · 1993 · 597 citations · Full text

Cross-talk between cellular signalling pathways suggested by phorbol-ester-induced adenylate cyclase phosphorylation

Takaaki Yoshimasa, David R. Sibley, Michel Bouvier et al. · Nature · 1987 · 521 citations

Signal Transduction, Signaling Pathway, Biochemistry +7

Rows per page

1–5 of 190